These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 17380085)
21. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Eisenstein BI; Oleson FB; Baltz RH Clin Infect Dis; 2010 Jan; 50 Suppl 1():S10-5. PubMed ID: 20067387 [TBL] [Abstract][Full Text] [Related]
22. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Carpenter CF; Chambers HF Clin Infect Dis; 2004 Apr; 38(7):994-1000. PubMed ID: 15034832 [TBL] [Abstract][Full Text] [Related]
23. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient]. Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009). Sader HS; Farrell DJ; Jones RN J Chemother; 2011 Aug; 23(4):200-6. PubMed ID: 21803696 [TBL] [Abstract][Full Text] [Related]
25. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia. Hair PI; Keam SJ Drugs; 2007; 67(10):1483-512. PubMed ID: 17600394 [TBL] [Abstract][Full Text] [Related]
26. Update on daptomycin: the first approved lipopeptide antibiotic. Lee SY; Fan HW; Kuti JL; Nicolau DP Expert Opin Pharmacother; 2006 Jul; 7(10):1381-97. PubMed ID: 16805723 [TBL] [Abstract][Full Text] [Related]
31. [New drugs; daptomycin]. van Bronswijk H; Dubois EA; van Dissel JT; Cohen AF Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2777-8. PubMed ID: 18232197 [TBL] [Abstract][Full Text] [Related]
32. Daptomycin in bone and joint infections: a review of the literature. Rice DA; Mendez-Vigo L Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance. Lee SY; Kuti JL; Nicolau DP Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938 [TBL] [Abstract][Full Text] [Related]
35. Daptomycin and tigecycline: a review of clinical efficacy in the antimicrobial era. Ziglam H Expert Opin Pharmacother; 2007 Oct; 8(14):2279-92. PubMed ID: 17927483 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of drug resistance: daptomycin resistance. Tran TT; Munita JM; Arias CA Ann N Y Acad Sci; 2015 Sep; 1354():32-53. PubMed ID: 26495887 [TBL] [Abstract][Full Text] [Related]
37. Current use of daptomycin in cardiac surgery and postoperative intensive care. Kanzler I; Weis F; Beiras-Fernandez A Expert Rev Anti Infect Ther; 2013 Mar; 11(3):309-20. PubMed ID: 23458770 [TBL] [Abstract][Full Text] [Related]